Aclaris Therapeutics, Inc. (ACRS)
USD 3.08
(-5.52%)
USD 3.08
(-5.52%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -78.32 Million | -67.56 Million | -52.13 Million | -38.63 Million | -96.44 Million | -100.81 Million |
| Net Income | -88.48 Million | -86.9 Million | -90.86 Million | -51.01 Million | -161.35 Million | -132.73 Million |
| Depreciation & Amortization | 863 Thousand | 797 Thousand | 923 Thousand | 1.32 Million | 6.4 Million | 1.87 Million |
| Deferred income taxes | -367 Thousand | - | 752 Thousand | -182 Thousand | 44.29 Million | - |
| Stock-based compensation | 20.54 Million | 15.03 Million | 14.06 Million | 11.2 Million | 16.17 Million | 20.05 Million |
| Change in working capital | 9.38 Million | -1.19 Million | -1.34 Million | -2.36 Million | -2.7 Million | 9.43 Million |
| Other non-cash items | -20.27 Million | 4.7 Million | 24.33 Million | 2.39 Million | 734 Thousand | 555 Thousand |
| Investing Cash Flow | 46.22 Million | 12.62 Million | -167.63 Million | 6.38 Million | 105.67 Million | 9.36 Million |
| Investments in PPE | -1.3 Million | -605 Thousand | -308 Thousand | -453 Thousand | -1.61 Million | -1.35 Million |
| Acquisitions | -47.52 Million | -13.23 Million | 167.32 Million | -6.84 Million | 34.18 Million | -67.12 Million |
| Investment purchases | -135.67 Million | -164.75 Million | -235.15 Million | -47.71 Million | -137.38 Million | -161.59 Million |
| Sales/Maturities of investments | 183.2 Million | 177.98 Million | 67.82 Million | 54.55 Million | 210.49 Million | 239.44 Million |
| Other Investing Activities | 47.52 Million | 13.23 Million | -167.32 Million | 6.84 Million | 34.18 Million | 77.84 Million |
| Financing Cash Flow | 26.7 Million | 72.86 Million | 225.05 Million | 18.37 Million | -30.31 Million | 128.26 Million |
| Debt repayment | - | - | -11.48 Million | -137 Thousand | -30.52 Million | -648 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -102 Thousand | -34 Thousand | -3.12 Million | 7.73 Million | - | - |
| Common Stock Issuance | 26.8 Million | 72.74 Million | 239.65 Million | 7.73 Million | 207 Thousand | 100.2 Million |
| Other Financing Activities | 26.8 Million | 157 Thousand | -3.12 Million | 10.77 Million | -30.31 Million | 28.7 Million |
| Accounts receivables | 186 Thousand | 139 Thousand | 149 Thousand | 4.89 Million | -809 Thousand | -4.38 Million |
| Accounts payables | -1.47 Million | 368 Thousand | 3.65 Million | -5.21 Million | -3.16 Million | 6.96 Million |
| Inventory | - | - | - | - | 605 Thousand | 102 Thousand |
| Other working capital | 1.28 Million | -1.7 Million | -5.14 Million | -2.03 Million | 661 Thousand | 6.75 Million |
| Cash at beginning of period | 45.27 Million | 27.34 Million | 22.06 Million | 35.93 Million | 57.01 Million | 20.2 Million |
| Cash at end of period | 39.87 Million | 45.27 Million | 27.34 Million | 22.06 Million | 35.93 Million | 57.01 Million |
| Capital Expenditure | -1.3 Million | -605 Thousand | -308 Thousand | -453 Thousand | -1.61 Million | -1.35 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -5.39 Million | 17.92 Million | 5.28 Million | -13.87 Million | -21.08 Million | 36.81 Million |
| Free Cash Flow | -79.63 Million | -68.17 Million | -52.44 Million | -39.08 Million | -98.05 Million | -102.16 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -10.98 Million | -16.94 Million | -1.49 Million | -88.48 Million | -29.26 Million | -29.56 Million |
| Depreciation & Amortization | 200 Thousand | 243 Thousand | 228 Thousand | 863 Thousand | 219 Thousand | 218 Thousand |
| Deferred income taxes | - | - | 6.26 Million | -367 Thousand | -635 Thousand | 198 Thousand |
| Stock-based compensation | 2.9 Million | 2.08 Million | 1.26 Million | 20.54 Million | 5.94 Million | 6.52 Million |
| Change in working capital | -4.68 Million | -9 Million | 13.27 Million | 9.38 Million | -3.16 Million | 3.67 Million |
| Other non-cash items | 7.03 Million | 3.51 Million | -26.3 Million | -20.27 Million | 2.33 Million | -1.69 Million |
| Investing Cash Flow | -674 Thousand | 16.83 Million | 7.55 Million | 46.22 Million | 32.53 Million | -19.66 Million |
| Investments in PPE | 14 Thousand | -135 Thousand | -441 Thousand | -1.3 Million | -84 Thousand | -231 Thousand |
| Acquisitions | - | - | 39.53 Million | -47.52 Million | -32.61 Million | 19.43 Million |
| Investment purchases | -35.21 Million | - | - | -135.67 Million | -17.16 Million | -89.98 Million |
| Sales/Maturities of investments | 34.53 Million | 16.96 Million | 7.99 Million | 183.2 Million | 49.78 Million | 70.55 Million |
| Other Investing Activities | -688 Thousand | 16.96 Million | 7.99 Million | 47.52 Million | 32.61 Million | -19.43 Million |
| Financing Cash Flow | -11 Thousand | -55 Thousand | 49 Thousand | 26.7 Million | -87 Thousand | 26.74 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -11 Thousand | -55 Thousand | 102 Thousand | -102 Thousand | -102 Thousand | - |
| Common Stock Issuance | - | - | 49 Thousand | 26.8 Million | 15 Thousand | 26.74 Million |
| Other Financing Activities | -11 Thousand | -55 Thousand | 49 Thousand | 26.8 Million | 15 Thousand | 26.74 Million |
| Accounts receivables | 48 Thousand | -75 Thousand | 48 Thousand | 186 Thousand | 85 Thousand | 255 Thousand |
| Accounts payables | -3.54 Million | 1.93 Million | -394 Thousand | -1.47 Million | -2.15 Million | 3.23 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.18 Million | -10.86 Million | 13.62 Million | 1.28 Million | -1.09 Million | 185 Thousand |
| Cash at beginning of period | 35.84 Million | 39.87 Million | 39.04 Million | 45.27 Million | 31.15 Million | 44.72 Million |
| Cash at end of period | 22.83 Million | 35.84 Million | 39.87 Million | 39.87 Million | 39.04 Million | 31.15 Million |
| Capital Expenditure | 14 Thousand | -135 Thousand | -441 Thousand | -1.3 Million | -84 Thousand | -231 Thousand |
| Effect of forex changes on cash | - | - | -17.06 Million | - | - | 17.06 Million |
| Net cash flow / Change in cash | -13 Million | -4.03 Million | 838 Thousand | -5.39 Million | 7.89 Million | -13.57 Million |
| Free Cash Flow | -12.3 Million | -20.95 Million | -7.2 Million | -79.63 Million | -24.64 Million | -20.88 Million |
MGTX
TSG
WFX
SYTAW
0QAV
AVA